Plain-English translation of NCT07070128 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Neoplasms research guide →Researchers are developing an artificial intelligence tool to better identify women who carry genetic changes that increase their breast cancer risk. The study will review your medical records and ask you questions about your family's cancer history to help train and test this new screening tool. This is not testing a medication, but rather a new way to predict who might benefit from genetic counseling and closer monitoring.
Currently, doctors rely on a patient's personal and family history to decide who should have genetic testing for breast cancer risk. This study aims to create a smarter, more accurate tool using artificial intelligence that could help catch women at high genetic risk earlier and connect them with the right care.
You likely qualify if…
You likely don't qualify if…
If you join, researchers will review your existing medical records and then ask you questions about your family history of cancer using an artificial intelligence chatbot. This is a one-time conversation — there is no medication to take or invasive procedures involved. The entire process takes place at one of two breast health centers in Brazil and is designed to be straightforward and respectful of your time.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
Brazil